EACS: Recommendations for treatment of HIV+ pregnant women

Pregnant women should be monitored every month and as close as possible to the predicted delivery date


ARVs used during pregnancy should be selected only if potential benefit justifies the potential risk1

1. EACS Guidelines 2011. Available at http://www.europeanaidsclinicalsociety.org/guidelinespdf/EACS-EuroGuidelines_FullVersion.pdf. Accessed March 2011; 2.SmPCs. Available at http://www.ema.europa.eu Accessed March 2011